AVTE - Aerovate Therapeutics, Inc.

QQQ $ 448.01 $ -1.07 (-0.24 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.96 $ -0.28 (-0.13 %)

Previous Close

$ 19.28

Open

$ 19.15

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 18.38 - $ 19.43

52 Week Range

$ 9.41 - $ 32.42

Volume

246,860

Average Volume

Market Cap

535.9M

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	03-25-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-29-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-30-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wedbush Reiterates Outperform on Aerovate ...
05/14/2024 12:34:43

Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.

Aerovate Therapeutics Q1 2024 GAAP EPS $(0...
05/13/2024 20:46:34

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate ...

ermenegildo-zegna-reports-fy23-results-joins-altice-usa-herbalife-and-other-big-stocks-moving-lower-on-friday

Ermenegildo Zegna Reports FY23 Results, Jo...
04/05/2024 14:27:21

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Friday. Shares of Ermenegildo Zegna N.V. (NYSE:...

Wells Fargo Maintains Overweight on Aerova...
04/01/2024 16:07:11

Wells Fargo analyst Tiago Fauth maintains Aerovate Therapeutics (NASDAQ:AVTE) with a Overweight and maintains $35 price target.

Aerovate Therapeutics To Present Patient B...
03/27/2024 13:28:07

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve ...

Recap: Aerovate Therapeutics Q4 Earnings
03/25/2024 21:20:05

Aerovate Therapeutics Expects Cash, Cash E...
03/25/2024 20:16:30

Aerovate Therapeutics Q4 2023 GAAP EPS $(0...
03/25/2024 20:15:29

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate ...

Jefferies Assumes Aerovate Therapeutics at...
03/25/2024 12:39:30

Jefferies analyst Eun Yang assumes Aerovate Therapeutics (NASDAQ:AVTE) with a Buy rating and raises Price Target to $65.

Aerovate Therapeutics Board Of Directors A...
03/06/2024 13:11:15

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve ...

Aerovate Reports Simultaneous Completion O...
11/20/2023 21:47:22

Aerovate Therapeutics Q3 EPS $(0.71) Misse...
11/13/2023 13:28:09

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate ...

Recap: Aerovate Therapeutics Q3 Earnings
11/13/2023 13:25:11

Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

During the session on Thursday, 461 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Friday
09/15/2023 15:52:24

Friday's session saw 169 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Monday
09/11/2023 17:38:28

Monday's session saw 175 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Friday
09/08/2023 17:58:01

Friday's session saw 225 companies set new 52-week lows.

Aerovate Therapeutics Q2 EPS $(0.76) Misse...
08/14/2023 12:31:11

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate ...

Aerovate Therapeutics Presents Nonclinical...
05/22/2023 17:29:46

Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared with oral or IV d...

Aerovate Therapeutics, Inc. Q1 EPS $(0.67)...
05/16/2023 04:12:47

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate ...